| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 63 |
| 1 | LIRAGLUTIDE | 42 |
| 2 | TIRZEPATIDE | 36 |
| 3 | METFORMIN | 35 |
| 4 | METFORMIN ER 500 MG | 33 |
| 5 | METFORMIN ER 750 MG | 33 |
| 6 | EXENATIDE | 22 |
| 7 | DULAGLUTIDE | 21 |
| 8 | INSULIN GLARGINE | 20 |
| 9 | LEVOTHYROXINE SODIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANDETANIB | 10 | 0.0055 |
| 1 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 2 | 0.0012 |
| 2 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 2 | 0.0010 |
| 3 | LIRAGLUTIDE | 42 | 0.0008 |
| 4 | ORAL SEMAGLUTIDE | 63 | 0.0008 |
| 5 | FLUOROMETHOLONE | 2 | 0.0006 |
| 6 | EXENATIDE | 22 | 0.0004 |
| 7 | MIFEPRISTONE | 2 | 0.0004 |
| 8 | ALFUZOSIN HYDROCHLORIDE | 1 | 0.0004 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 175 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 36 |
| 2 | Insulin Analog [EPC] | 33 |
| 3 | Corticosteroid [EPC] | 21 |
| 4 | Kinase Inhibitor [EPC] | 18 |
| 5 | Sulfonylurea [EPC] | 18 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 8 | Alkylating Drug [EPC] | 12 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Progestin Antagonist [EPC] | 2 | 0.0004 |
| 2 | GLP-1 Receptor Agonist [EPC] | 175 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 4 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 7 | 0.0002 |
| 5 | Vitamin D3 Analog [EPC] | 4 | 0.0002 |
| 6 | Sulfonylurea [EPC] | 18 | 0.0001 |
| 7 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 8 | Insulin [EPC] | 6 | 0.0001 |
| 9 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |